Consistent with these results, stable expression of a hnRNPL ΔRRM3 mutant that cannot be recognized and degraded by FBXO16 significantly enhanced ovarian cancer cell proliferation, clonogenic survival, and cell invasion in vitro (Fig. 6F–H). The gene discussed is HNRNPL; the disease is ovarian carcinoma.